(Q27011661)

English

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group

scientific article

In more languages

Statements

scholarly article

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group (English)

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Michael J Zelefsky

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Patrick A. Kupelian

8

object named as

Patrick Kupelian

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

5

object named as

Steven Frank

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Peter Grimm

1

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Ignace Billiet

2

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

David Bostwick

3

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Jos Immerzeel

6

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Mira Keyes

7

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Stefan Machtens

10

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Jyoti Mayadev

11

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Gregory Merrick

13

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Richard Stock

16

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Katsuto Shinohara

17

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Mark Scholz

18

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Ed Weber

19

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Anthony Zietman

20

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Jason Wong

22

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Stacy Wentworth

23

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Robyn Vera

24

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Stephen Langley

25

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

W Robert Lee

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Brian J Moran

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Mack Roach

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

1 reference

publication date

1 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

BJU International

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

109 Suppl 1

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

22-29

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Biochemical recurrence following robot-assisted radical prostatectomy: analysis of 1384 patients with a median 5-year follow-up.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Equivalent biochemical control and improved prostate-specific antigen nadir after permanent prostate seed implant brachytherapy versus high-dose three-dimensional conformal radiotherapy and high-dose conformal proton beam radiotherapy boost

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Permanent prostate implant using high activity seeds and inverse planning with fast simulated annealing algorithm: A 12-year Canadian experience.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Prognostic significance of perineural invasion on biochemical progression-free survival after prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Brachytherapy or conformal external radiotherapy for prostate cancer: a single-institution matched-pair analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Natural history of clinically staged low- and intermediate-risk prostate cancer treated with monotherapeutic permanent interstitial brachytherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Comparison of tumor control and toxicity outcomes of high-dose intensity-modulated radiotherapy and brachytherapy for patients with favorable risk prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Ten-year outcomes: the clinical utility of single photon emission computed tomography/computed tomography capromab pendetide (Prostascint) in a cohort diagnosed with localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Increasing external beam dose for T1-T2 prostate cancer: effect on risk groups

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Outcomes for intermediate risk prostate cancer: are there advantages for surgery, external radiation, or brachytherapy?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Outcomes from Gleason 7, intermediate risk, localized prostate cancer treated with Iodine-125 monotherapy over 10 years.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Long-term outcomes for patients with prostate cancer having intermediate and high-risk disease, treated with combination external beam irradiation and brachytherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

High dose rate brachytherapy as a boost for the treatment of localized prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Comparing results after surgery in patients with clinical unilateral T3a prostate cancer treated with or without neoadjuvant androgen-deprivation therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Long-term survival after radical prostatectomy for men with high Gleason sum in pathologic specimen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Whole-pelvis radiotherapy in combination with interstitial brachytherapy: does coverage of the pelvic lymph nodes improve treatment outcome in high-risk prostate cancer?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: Importance of patient selection and implant quality

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

The relationship between the biochemical control outcomes and the quality of planning of high-dose rate brachytherapy as a boost to external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

The specific definition of high risk prostate cancer has minimal impact on biochemical relapse-free survival

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10827.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2011.10827.X

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

release_vhbsaoaprvhw5n5sobsfoh4lxa

1 reference

https://api.fatcat.wiki/v0/release/vhbsaoaprvhw5n5sobsfoh4lxa

24 November 2022

based on heuristic

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22239226%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27011661&oldid=2058330904"